Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2009-05-07
2010-11-16
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S577000, C514S859000, C424S401000
Reexamination Certificate
active
07834060
ABSTRACT:
Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
REFERENCES:
patent: 4717720 (1988-01-01), Shroot et al.
patent: 5212303 (1993-05-01), Shroot et al.
patent: RE34440 (1993-11-01), Shroot et al.
patent: 5306486 (1994-04-01), McCook et al.
patent: 5603940 (1997-02-01), Candau et al.
patent: 5665364 (1997-09-01), McAtee et al.
patent: 6383505 (2002-05-01), Kaiser et al.
patent: 6413536 (2002-07-01), Gibson et al.
patent: 7083799 (2006-08-01), Giacomoni
patent: 2003/0157138 (2003-08-01), Eini et al.
patent: 2005/0059740 (2005-03-01), Graeber et al.
patent: 0 199 636 (1986-10-01), None
patent: 0 487 973 (1996-03-01), None
patent: 0 487 973 (1996-03-01), None
patent: 2 730 930 (1996-08-01), None
patent: WO 01/28552 (2001-04-01), None
patent: WO 02/083086 (2002-10-01), None
“Topical Formulary for Carbopol® Polymers”, Noveon, Inc., The Specialty Chemicals Innovator, Pharmaceutical Polymers, pp. 1-25, Jan. 2002, Cleveland, Ohio.
Body Cream, Phytosan™, Formula No. 416.09.0077.
Jamoulle et al., “Follicular Penetration and Distribution of Topically Applied CD 271, a new Naphthoic Acid Derivative Intended for Topical Acne Treatment”,Journal of Investigative Dermatology, (1990), 94(5), 731-732, published by Nature Publishing Group.
Allec et al., “Skin didtribution and pharmaceutical aspects of adapalene gel,”J. Am. Acad. Dermatol.(1997) 36:S119-S125, published by American Academy of Dermatology, Inc., US.
Shroot et al., “A New Concept of Drug Delivery for Acne”,Dermatology(1998), 196:165-170, published by S. Karger AG, Switzerland.
Rolland et al., “Site-specific Drug Delivery to Pilosebaceous Structures Using Polymeric Microspheres”,Pharmaceutical Research(1993), vol. 10, No. 12, 1738-1744, published by Plenum Publishing Corporation.
Alirezai et al., “Etude Comparative de l'efficacité et de la tolérance de gels d'adapalène à 0,1 et 0,03 p 100 et d'un gel de trétimoïne á 0,025 p 100 dans le traitement de l'acné” (Effićacy and safety comparison study of 0.1 p. 100 and 0.03 p 100 adapalene gels and tretinoin gel in the topical treatment of acne),Ann. Dermatol. Venereol. (1996), 123:165-170, published by Paris Masson, Paris, France (Extensive summary in English).
Healy et al. “Acnevulgaris”,British Medical Journal, 1994 vol. 308, Iss. 6932, pp. 2-9.
Czernielewski et al. “Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne”,Journal of European Academy of Dermatology and Venerology, Dec. 2001, vol. 15, Supplement 3, pp. 5-12.
Differin Gel Data Sheet (Differin Gel Data Sheet available as of Nov. 1998), pp. 1-5.
Talukdar et al.,Journal of Pharmaceutical Sciences, May 1996, vol. 85, No. 5, pp. 537-540.
Sepicontrol A5, Aug. 2001, pp. 1-53.
International Search Report for corresponding PCT/EP03/03246 (WO 03/075908 A1) in English.
Protest Under 37 C.F.R. § 1.291 regarding U.S. Appl. No. 11/494,693 (US 2007/0043119) with attachments dated Jun. 14, 2008.
Notification of Non-entry of Protest.
European Search Report for EP 05 003144 (in English).
Minutes for Oral Proceedings for European Application EP 03712109 corresponding to parent U.S. Appl. No. 10/937,612.
Czernielewski Janusz
Graeber Michael
Buchanan & Ingersoll & Rooney PC
Galderma Research & Development
Jean-Louis Samira
Padmanabhan Sreeni
LandOfFree
Administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4159732